OBJECTIVE: To compare CT volume analysis with MR perfusion imaging in differentiating smokers with normal pulmonary function (controls) from COPD patients. METHODS: Sixty-two COPD patients and 17 controls were included. The total lung volume (TLV), total emphysema volume (TEV) and emphysema index (EI) were quantified by CT. MR perfusion evaluated positive enhancement integral (PEI), maximum slope of increase (MSI), maximum slope of decrease (MSD), signal enhancement ratio (SER) and signal intensity ratio (RSI) of perfusion defects to normal lung. RESULTS: There were 19 class I, 17 class II, 14 class III and 12 class IV COPD patients. No differences were observed in TLV, TEV and EI between control and class I COPD. The control was different from class II, III and IV COPD in TEV and EI. The control was different from each class of COPD in RSI, MSI, PEI and MSD. Differences were found in RSI between class I and III, I and IV, and II and IV COPD. Amongst controls, MR detected perfusion defects more frequently than CT detected emphysema. CONCLUSIONS: Compared with CT, MR perfusion imaging shows higher potential to distinguish controls from mild COPD and appears more sensitive in identifying abnormalities amongst smokers with normal pulmonary function (controls). KEY POINTS: • Detailed information is needed to diagnose chronic obstructive pulmonary disease. • High-resolution CT provides detailed anatomical and quantitative information. • Magnetic resonance imaging is demonstrating increasing potential in pulmonary function imaging. • MR perfusion can distinguish mild COPD patients from controls. • MRI appears more sensitive than CT in identifying early abnormalities amongst controls.
OBJECTIVE: To compare CT volume analysis with MR perfusion imaging in differentiating smokers with normal pulmonary function (controls) from COPDpatients. METHODS: Sixty-two COPDpatients and 17 controls were included. The total lung volume (TLV), total emphysema volume (TEV) and emphysema index (EI) were quantified by CT. MR perfusion evaluated positive enhancement integral (PEI), maximum slope of increase (MSI), maximum slope of decrease (MSD), signal enhancement ratio (SER) and signal intensity ratio (RSI) of perfusion defects to normal lung. RESULTS: There were 19 class I, 17 class II, 14 class III and 12 class IV COPDpatients. No differences were observed in TLV, TEV and EI between control and class I COPD. The control was different from class II, III and IV COPD in TEV and EI. The control was different from each class of COPD in RSI, MSI, PEI and MSD. Differences were found in RSI between class I and III, I and IV, and II and IV COPD. Amongst controls, MR detected perfusion defects more frequently than CT detected emphysema. CONCLUSIONS: Compared with CT, MR perfusion imaging shows higher potential to distinguish controls from mild COPD and appears more sensitive in identifying abnormalities amongst smokers with normal pulmonary function (controls). KEY POINTS: • Detailed information is needed to diagnose chronic obstructive pulmonary disease. • High-resolution CT provides detailed anatomical and quantitative information. • Magnetic resonance imaging is demonstrating increasing potential in pulmonary function imaging. • MR perfusion can distinguish mild COPDpatients from controls. • MRI appears more sensitive than CT in identifying early abnormalities amongst controls.
Authors: Thomas Ritz; Bernhard Dahme; Arthur B Dubois; Hans Folgering; Gregory K Fritz; Andrew Harver; Harry Kotses; Paul M Lehrer; Christopher Ring; Andrew Steptoe; Karel P Van de Woestijne Journal: Psychophysiology Date: 2002-09 Impact factor: 4.016
Authors: Song Soo Kim; Joon Beom Seo; Namkug Kim; Eun Jin Chae; Young Kyung Lee; Yeon Mok Oh; Sang Do Lee Journal: Eur J Radiol Date: 2012-05-20 Impact factor: 3.528
Authors: Andrew J Swift; Jim M Wild; Stan Fichele; Neil Woodhouse; Sally Fleming; Judith Waterhouse; Rod A Lawson; Martyn N J Paley; Edwin J R Van Beek Journal: Eur J Radiol Date: 2005-06 Impact factor: 3.528
Authors: Hester A Gietema; Pieter Zanen; Arnold Schilham; Bram van Ginneken; Rob J van Klaveren; Mathias Prokop; Jan Willem J Lammers Journal: Respir Med Date: 2009-09-06 Impact factor: 3.415
Authors: Katja Hueper; Jens Vogel-Claussen; Megha A Parikh; John H M Austin; David A Bluemke; James Carr; Jiwoong Choi; Thomas A Goldstein; Antoinette S Gomes; Eric A Hoffman; Steven M Kawut; Joao Lima; Erin D Michos; Wendy S Post; Ming Jack Po; Martin R Prince; Kiang Liu; Dan Rabinowitz; Jan Skrok; Ben M Smith; Karol Watson; Youbing Yin; Alan M Zambeli-Ljepovic; R Graham Barr Journal: Am J Respir Crit Care Med Date: 2015-09-01 Impact factor: 21.405
Authors: Eric A Hoffman; David A Lynch; R Graham Barr; Edwin J R van Beek; Grace Parraga Journal: J Magn Reson Imaging Date: 2015-07-22 Impact factor: 4.813
Authors: Yu Pu; Xiuxiu Zhou; Di Zhang; Yu Guan; Yi Xia; Wenting Tu; Yang Lu; Weidong Zhang; Chi-Cheng Fu; Qu Fang; Geertruida H de Bock; Shiyuan Liu; Li Fan Journal: Int J Chron Obstruct Pulmon Dis Date: 2022-10-04
Authors: Bertram J Jobst; Mark O Wielpütz; Simon M F Triphan; Angela Anjorin; Julia Ley-Zaporozhan; Hans-Ulrich Kauczor; Jürgen Biederer; Sebastian Ley; Oliver Sedlaczek Journal: PLoS One Date: 2015-09-01 Impact factor: 3.240